Effect of meditation or escitalopram on work performance in patients with anxiety disorders
Journal of Affective Disorders · 2024
DOI: 10.1016/j.jad.2024.08.019 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Affective Disorders, 2024. Verfasst von Anna C Oft und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Georgetown University Medical Center, Washington, DC, USA. Electronic address: aco51@georgetown.edu. Hauptthemen laut MEDLINE: Anxiety Disorders, Work Performance, Escitalopram, Meditation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: PCORI.
Abstract (Originalsprache)
OBJECTIVE: This study aimed to 1) examine how psychopharmacotherapy and mindfulness-based stress reduction (MBSR) influence absenteeism and job performance among individuals with anxiety disorders and 2) compare the effectiveness of these treatments in improving work performance. METHODS: Adults (N = 67) with a primary anxiety disorder were recruited to participate in the study. Participants were randomized to escitalopram, a common treatment for anxiety disorders, or MBSR. Absenteeism and job performance were measured with the Health and Work Performance (HPQ) questionnaire prior to treatment and at the week 24 follow up. RESULTS: At week 24, individuals in the escitalopram arm and the MBSR arm showed significant improvements in partial days of missed work due to mental/physical health problems from baseline (1.00 [0.00-2.50] to 0.00 [0.00 = 1.00], p = .034 and 0.00 [0.00-2.00] to 0.00 [0.00 = 1.00], p = .001, respectively). In the MBSR arm only, job performance increased from baseline to week 24 (65.00 [50.00-80.00] to 75.00 [67.50-82.50], p = .017). None of the outcome variables significantly varied by group at baseline or week 24. CONCLUSIONS: Our study finds evidence that MBSR improves work performance equivalently to SSRI medication among individuals with anxiety disorders. Given the limitations of SSRIs, MBSR should be considered as an alternative to individuals who desire improved anxiety symptoms and work outcomes. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03522844.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Georgetown University Medical Center, Washington, DC, USA. Electronic address: aco51@georgetown.edu.
- Department of Psychological and Brain Sciences, Texas A&M University, 4235 TAMU, College Station, TX 77840, USA. Electronic address: srphilip@tamu.edu.
- Department of Psychiatry, Georgetown University Medical Center, Washington, DC, USA. Electronic address: eh933@georgetown.edu.
- Department of Psychiatry, Georgetown University Medical Center, Washington, DC, USA. Electronic address: sss286@georgetown.edu.
- Department of Psychiatry, Georgetown University Medical Center, Washington, DC, USA. Electronic address: xg59@georgetown.edu.
- Department of Psychiatry, Georgetown University Medical Center, Washington, DC, USA. Electronic address: eah103@georgetown.edu.
Förderung
- PCORI
Zitieren
APA
Oft, A. C., Philip, S., Holz, E., Sathi, S., Geng, X., & Hoge, E. (2024). Effect of meditation or escitalopram on work performance in patients with anxiety disorders. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2024.08.019
Vancouver
Oft AC, Philip S, Holz E, Sathi S, Geng X, Hoge E. Effect of meditation or escitalopram on work performance in patients with anxiety disorders. Journal of Affective Disorders. 2024. doi:10.1016/j.jad.2024.08.019
BibTeX
@article{Oft2024,
author = {Oft, Anna C and Philip, Samantha and Holz, Emily and Sathi, Sruveera and Geng, Xue and Hoge, Elizabeth},
title = {Effect of meditation or escitalopram on work performance in patients with anxiety disorders},
journal = {Journal of Affective Disorders},
year = {2024},
doi = {10.1016/j.jad.2024.08.019}
}
EUVIMED